Karine Charlot, MD Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 240a Long Island Ave, Wyandanch, NY 11798 Phone: 631-782-6200 |
Usha Joshi, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 240 Long Island Ave, Wyandanch, NY 11798 Phone: 631-920-8280 |
News Archive
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, today provided a review of recent accomplishments for shareholders and investors.
The Wall Street Journal/Dow Jones: "Senate Democrats appear ... closer to reaching agreement on an alternative to a government-run health-insurance plan in health-care overhaul legislation, even as they dealt with disagreement within their party on abortion. Sen. Debbie Stabenow, (D., Mich.) told reporters Monday that Democrats are 'rapidly coming to a conclusion' on language within the bill, including a public-plan alternative."
If you are obese and hope to be a father, here's another reason to lose weight: your children and grandchildren may inherit your waistline or metabolic disorders. That's because scientists have discovered in mice that obese fathers, even those who did not show any signs of diabetes, passed this negative trait on most frequently to their daughters. Sons don't entirely dodge this genetic bullet either-both sons and daughters of obese fathers have increased risks of developing metabolic diseases, such as diabetes.
One of the most frequent is the existence of tumours that induce an over-secretion of this hormone. These women present with chronic infertility due to anovulation. Thanks to the work of the Inserm researchers from unit 693 "Steroid receptors: endocrinian and metabolic physiopathology", the intimate mechanism of the hyperprolactinaemia alterations affecting reproduction in mice has been discovered.
The Gruenenthal Group and Forest Laboratories, Inc., today announced that Forest Healthcare B.V., a wholly owned subsidiary of Forest Laboratories, Inc. and Gruenenthal GmbH, have entered into an agreement whereby Forest has acquired all rights currently held by Gruenenthal for colistin and all rights previously licensed by Forest to Gruenenthal for Colobreathe.
› Verified 9 days ago